Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes

ClinicalTrials.gov ID: NCT04164966

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04164966. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the levels of certain substances (biomarkers) in the body that may indicate the triggers of Type 1 Diabetes, to find a better way to diagnose the disease, as well as to follow its progression.

Study identification

NCT ID: NCT04164966
Recruitment status: Active, not recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: AdventHealth Translational Research Institute; Other
Enrollment: 28 participants

Conditions and interventions

Conditions

Type 1 Diabetes

Interventions

Not listed

Eligibility (public fields only)

Age range: 12 Years to 18 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 27, 2019 (Actual)
Primary completion: Jul 23, 2024 (Actual)
Completion: Dec 2026 (Estimated)
Last update posted: Mar 30, 2026

2019 – 2026

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
AdventHealth Translational Research Institute	Orlando	Florida	32804	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04164966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 30, 2026 · Synced Nov 14, 2026